Ballentine Partners LLC increased its holdings in shares of Welltower Inc. (NYSE:WELL – Free Report) by 9.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,739 shares of the real estate investment trust’s stock after buying an additional 811 shares during the period. Ballentine Partners LLC’s holdings in Welltower were worth $1,497,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently made changes to their positions in WELL. Brighton Jones LLC lifted its position in shares of Welltower by 7.1% during the 4th quarter. Brighton Jones LLC now owns 4,185 shares of the real estate investment trust’s stock valued at $527,000 after buying an additional 279 shares in the last quarter. Wood Tarver Financial Group LLC purchased a new position in Welltower in the 4th quarter valued at $54,000. Centaurus Financial Inc. lifted its holdings in Welltower by 2,074.5% in the 4th quarter. Centaurus Financial Inc. now owns 17,135 shares of the real estate investment trust’s stock valued at $2,159,000 after purchasing an additional 16,347 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Welltower by 0.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 121,080 shares of the real estate investment trust’s stock valued at $15,260,000 after purchasing an additional 946 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its holdings in Welltower by 14.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 2,406 shares of the real estate investment trust’s stock valued at $369,000 after purchasing an additional 297 shares in the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.
Welltower Stock Up 0.4%
Shares of WELL opened at $171.69 on Friday. Welltower Inc. has a 52-week low of $122.34 and a 52-week high of $173.22. The company has a market capitalization of $114.83 billion, a PE ratio of 97.00, a price-to-earnings-growth ratio of 1.92 and a beta of 0.93. The stock has a fifty day simple moving average of $166.17 and a two-hundred day simple moving average of $155.47. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.44.
Welltower Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 21st. Investors of record on Tuesday, August 12th were given a dividend of $0.74 per share. This represents a $2.96 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Tuesday, August 12th. This is a positive change from Welltower’s previous quarterly dividend of $0.67. Welltower’s dividend payout ratio is 167.23%.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. Wells Fargo & Company raised their price objective on Welltower from $175.00 to $185.00 and gave the company an “overweight” rating in a report on Wednesday, August 27th. Raymond James Financial restated a “strong-buy” rating on shares of Welltower in a report on Tuesday, September 2nd. KeyCorp raised their price objective on Welltower from $150.00 to $200.00 and gave the company an “overweight” rating in a report on Tuesday. UBS Group assumed coverage on Welltower in a report on Friday, September 19th. They issued a “buy” rating and a $195.00 price objective on the stock. Finally, Scotiabank raised their price objective on Welltower from $172.00 to $181.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Welltower presently has a consensus rating of “Moderate Buy” and an average price target of $179.42.
Read Our Latest Research Report on WELL
Insider Activity
In other Welltower news, Director Andrew Gundlach acquired 20,000 shares of the business’s stock in a transaction that occurred on Monday, June 30th. The stock was purchased at an average cost of $151.46 per share, with a total value of $3,029,200.00. Following the transaction, the director owned 20,000 shares of the company’s stock, valued at $3,029,200. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.21% of the company’s stock.
About Welltower
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
Featured Stories
- Five stocks we like better than Welltower
- Best Stocks Under $5.00
- Lower Rates Put RV Stocks Back in the Fast Lane
- How to Invest in the FAANG Stocks
- Alphabet: Time to Take Profits, Buy, or Wait for a Pullback?
- Investing in Commodities: What Are They? How to Invest in Them
- Hershey vs. Mondelez: Which Stock Wins Chocolate Season?
Want to see what other hedge funds are holding WELL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Welltower Inc. (NYSE:WELL – Free Report).
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.